Noncoding RNAs: Emerging players in muscular dystrophies

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Falcone, Germana ^a   Perfetti, Alessandra ^b   Cardinali, Beatrice ^a   Martelli, Fabio ^b  

^a CNR   (Italy)

^b IRCCS POLICLINICO SAN DONATO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; UNTRANSLATED RNA; MUSCLE PROTEIN;

BECKER MUSCULAR DYSTROPHY; DISEASE MARKER; DUCHENNE MUSCULAR DYSTROPHY; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; HUMAN; MUSCLE DEVELOPMENT; MUSCULAR DYSTROPHY; NONHUMAN; REVIEW; ANIMAL; BIOLOGICAL MODEL; GENETIC PREDISPOSITION; GENETICS; PATHOPHYSIOLOGY; SKELETAL MUSCLE;

ANIMALS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MODELS, GENETIC; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; RNA, UNTRANSLATED;

EID: 84897901920     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/503634     Document Type: Review

References (123)

1. Winter J., Jung S., Keller S., Gregory R. I., Diederichs S., Many roads to maturity: microRNA biogenesis pathways and their regulation. Nature Cell Biology 2009 11 3 228 234 2-s2.0-61849137222 10.1038/ncb0309-228
2. Krol J., Loedige I., Filipowicz W., The widespread regulation of microRNA biogenesis, function and decay. Nature Reviews Genetics 2010 11 9 597 610 2-s2.0-77955902024 10.1038/nrg2843
3. Bartel D. P., MicroRNAs: target recognition and regulatory functions. Cell 2009 136 2 215 233 2-s2.0-58249088751 10.1016/j.cell.2009.01.002
4. Pasquinelli A. E., MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nature Reviews Genetics 2012 13 4 271 282 2-s2.0-84858446579 10.1038/nrg3162
5. Lee Y., Ahn C., Han J., Choi H., Kim J., Yim J., Lee J., Provost P., Rådmark O., Kim S., Kim V. N., The nuclear RNase III Drosha initiates microRNA processing. Nature 2003 425 6956 415 419 2-s2.0-0141843656 10.1038/nature01957 (Pubitemid 37187272)
6. Yi R., Qin Y., Macara I. G., Cullen B. R., Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes and Development 2003 17 24 3011 3016 2-s2.0-0347361541 10.1101/gad.1158803 (Pubitemid 38040764)
7. Lund E., Güttinger S., Calado A., Dahlberg J. E., Kutay U., Nuclear export of microRNA precursors. Science 2004 303 5654 95 98 2-s2.0-0347988235 10.1126/science.1090599 (Pubitemid 38055779)
8. Rand T. A., Petersen S., Du F., Wang X., Argonaute2 cleaves the anti-guide strand of siRNA during RISC activation. Cell 2005 123 4 621 629 2-s2.0-27744506761 10.1016/j.cell.2005.10.020 (Pubitemid 41608465)
9. Diederichs S., Haber D. A., Dual role for argonautes in microRNA processing and Posttranscriptional regulation of microRNA expression. Cell 2007 131 6 1097 1108 2-s2.0-36849048778 10.1016/j.cell.2007.10.032 (Pubitemid 350235019)
10. Czech B., Hannon G. J., Small RNA sorting: matchmaking for argonautes. Nature Reviews Genetics 2011 12 1 19 31 2-s2.0-78650306521 10.1038/nrg2916
11. Huntzinger E., Izaurralde E., Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nature Reviews Genetics 2011 12 2 99 110 2-s2.0-78751477191 10.1038/nrg2936
12. Fabian M. R., Sonenberg N., The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nature Structural & Molecular Biology 2012 19 6 586 593
13. Meijer H. A., Kong Y. W., Lu W. T., Wilczynska A., Spriggs R. V., Robinson S. W., Godfrey J. D., Willis A. E., Bushell M., Translational repression and eIF4A2 activity are critical for microRNA-mediated gene regulation. Science 2013 340 6128 82 85 10.1126/science.1231197
14. Rajewsky N., MicroRNA target predictions in animals. Nature Genetics 2006 38 1 S8 S13 2-s2.0-33745248430 10.1038/ng1798
15. Rinn J. L., Chang H. Y., Genome regulation by long noncoding RNAs. Annual Review of Biochemistry 2012 81 145 166 10.1146/annurev-biochem-051410-092902
16. Djebali S., Davis C. A., Merkel A., Landscape of transcription in human cells. Nature 2012 489 7414 101 108 10.1038/nature11233
17. Mercer T. R., Dinger M. E., Mattick J. S., Long non-coding RNAs: insights into functions. Nature Reviews Genetics 2009 10 3 155 159 2-s2.0-60349120914 10.1038/nrg2521
18. Guttman M., Garber M., Levin J. Z., Donaghey J., Robinson J., Adiconis X., Fan L., Koziol M. J., Gnirke A., Nusbaum C., Rinn J. L., Lander E. S., Regev A., Erratum: Ab initio reconstruction of cell type-specific transcriptomes in mouse reveals the conserved multi-exonic structure of lincRNAs (Nat. Biotechnol. (2010) 28 (503-510)). Nature Biotechnology 2010 28 7 756 2-s2.0-77954527753 10.1038/nbt0710-756b
19. Cabili M., Trapnell C., Goff L., Koziol M., Tazon-Vega B., Regev A., Rinn J. L., Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes and Development 2011 25 18 1915 1927 2-s2.0-80052978224 10.1101/gad.17446611
20. Khalil A. M., Guttman M., Huarte M., Garber M., Raj A., Morales D. R., Thomas K., Presser A., Bernstein B. E., Van Oudenaarden A., Regev A., Lander E. S., Rinn J. L., Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proceedings of the National Academy of Sciences of the United States of America 2009 106 28 11667 11672 2-s2.0-67650921949 10.1073/pnas.0904715106
21. Wang K. C., Chang H. Y., Molecular mechanisms of long noncoding RNAs. Molecular Cell 2011 43 6 904 914 2-s2.0-80053045739 10.1016/j.molcel.2011.08.018
22. Beltran M., Puig I., Peña C., García J. M., Álvarez A. B., Peña R., Bonilla F., De Herreros A. G., A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition. Genes and Development 2008 22 6 756 769 2-s2.0-41149112564 10.1101/gad.455708 (Pubitemid 351439107)
23. Tripathi V., Ellis J. D., Shen Z., Song D. Y., Pan Q., Watt A. T., Freier S. M., Bennett C. F., Sharma A., Bubulya P. A., Blencowe B. J., Prasanth S. G., Prasanth K. V., The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Molecular Cell 2010 39 6 925 938 2-s2.0-77956927823 10.1016/j.molcel.2010.08.011
24. Cabianca D. S., Casa V., Gabellini D., A novel molecular mechanism in human genetic disease A DNA repeat-derived lncRNA. RNA Biology 2012 9 10 1211 1217 10.4161/rna.21922
25. Ørom U. A., Shiekhattar R., Noncoding RNAs and enhancers: complications of a long-distance relationship. Trends in Genetics 2011 27 10 433 439 2-s2.0-80052815461 10.1016/j.tig.2011.06.009
26. Mousavi K., Zare H., Dell'orso S., Grontved L., Gutierrez-Cruz G., Derfoul A., Hager G. L., Sartorelli V., eRNAs promote transcription by establishing chromatin accessibility at defined genomic loci. Molecular Cell 2013 51 5 606 617 10.1016/j.molcel.2013.07.022
27. Salmena L., Poliseno L., Tay Y., Kats L., Pandolfi P. P., A ceRNA hypothesis: the rosetta stone of a hidden RNA language? Cell 2011 146 3 353 358 2-s2.0-79961170994 10.1016/j.cell.2011.07.014
28. Cesana M., Cacchiarelli D., Legnini I., Santini T., Sthandier O., Chinappi M., Tramontano A., Bozzoni I., Erratum: A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA (Cell (2011) 147 (358-369)). Cell 2011 147 4 947 2-s2.0-81055140881 10.1016/j.cell.2011.10. 031
29. Alexander M. S., Kawahara G., Motohashi N., Casar J. C., Eisenberg I., Myers J. A., Gasperini M. J., Estrella E. A., Kho A. T., Mitsuhashi S., Shapiro F., Kang P. B., Kunkel L. M., MicroRNA-199a is induced in dystrophic muscle and affects WNT signaling, cell proliferation, and myogenic differentiation. Cell Death and Differentiation 2013 20 9 1194 1208 10.1038/cdd.2013.62
30. Eisenberg I., Eran A., Nishino I., Moggio M., Lamperti C., Amato A. A., Lidov H. G., Kang P. B., North K. N., Mitrani-Rosenbaum S., Flanigan K. M., Neely L. A., Whitney D., Beggs A. H., Kohane I. S., Kunkel L. M., Distinctive patterns of microRNA expression in primary muscular disorders. Proceedings of the National Academy of Sciences of the United States of America 2007 104 43 17016 17021 2-s2.0-36749019110 10.1073/pnas.0708115104 (Pubitemid 350210983)
31. McCarthy J. J., Esser K. A., Andrade F. H., MicroRNA-206 is overexpressed in the diaphragm but not the hindlimb muscle of mdx mouse. The American Journal of Physiology-Cell Physiology 2007 293 1 C451 C457 2-s2.0-34547114014 10.1152/ajpcell.00077.2007 (Pubitemid 47105025)
32. Yuasa K., Hagiwara Y., Ando M., Nakamura A., Takeda S., Hijikata T., MicroRNA-206 is highly expressed in newly formed muscle fibers: implications regarding potential for muscle regeneration and maturation in muscular dystrophy. Cell Structure and Function 2008 33 2 163 169 2-s2.0-58149151370 10.1247/csf.08022
33. Greco S., De Simone M., Colussi C., Zaccagnini G., Fasanaro P., Pescatori M., Cardani R., Perbellini R., Isaia E., Sale P., Meola G., Capogrossi M. C., Gaetano C., Martelli F., Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia. The FASEB Journal 2009 23 10 3335 3346 2-s2.0-70349668311 10.1096/fj.08-128579
34. Alexander M. S., Casar J. C., Motohashi N., Myers J. A., Eisenberg I., Gonzalez R. T., Estrella E. A., Kang P. B., Kawahara G., Kunkel L. M., Regulation of DMD pathology by an ankyrin-encoded miRNA. Skelet Muscle 2011 1, article 27 10.1186/2044-5040-1-27
35. de Arcangelis V., Serra F., Cogoni C., Vivarelli E., Monaco L., Naro F., β 1-syntrophin modulation by miR-222 in mdx mice. PLoS ONE 2010 5 8 2-s2.0-77957778853 10.1371/journal.pone.0012098 e12098
36. Cacchiarelli D., Incitti T., Martone J., Cesana M., Cazzella V., Santini T., Sthandier O., Bozzoni I., MiR-31 modulates dystrophin expression: new implications for Duchenne muscular dystrophy therapy. EMBO Reports 2011 12 2 136 141 2-s2.0-79551594779 10.1038/embor.2010.208
37. Rau F., Freyermuth F., Fugier C., Villemin J.-P., Fischer M.-C., Jost B., Dembele D., Gourdon G., Nicole A., Duboc D., Wahbi K., Day J. W., Fujimura H., Takahashi M. P., Auboeuf D., Dreumont N., Furling D., Charlet-Berguerand N., Misregulation of miR-1 processing is associated with heart defects in myotonic dystrophy. Nature Structural and Molecular Biology 2011 18 7 840 845 2-s2.0-79960066418 10.1038/nsmb.2067
38. Gambardella S., Rinaldi F., Lepore S. M., Viola A., Loro E., Angelini C., Vergani L., Novelli G., Botta A., Overexpression of microRNA-206 in the skeletal muscle from myotonic dystrophy type 1 patients. Journal of Translational Medicine 2010 8, article 48 2-s2.0-77952369117 10.1186/1479-5876-8-48
39. Perbellini R., Greco S., Sarra-Ferraris G., Cardani R., Capogrossi M. C., Meola G., Martelli F., Dysregulation and cellular mislocalization of specific miRNAs in myotonic dystrophy type 1. Neuromuscular Disorders 2011 21 2 81 88 2-s2.0-78751567960 10.1016/j.nmd.2010.11.012
40. Fernandez-Costa J. M., Garcia-Lopez A., Zuniga S., Fernandez-Pedrosa V., Felipo-Benavent A., Mata M., Jaka O., Aiastui A., Hernandez-Torres F., Aguado B., Perez-Alonso M., Vilchez J. J., de Munain A. L., Artero R. D., Expanded CTG repeats trigger miRNA alterations in Drosophila that are conserved in myotonic dystrophy type 1 patients. Human Molecular Genetics 2013 22 4 704 716 10.1093/hmg/dds478
41. Greco S., Perfetti A., Fasanaro P., Cardani R., Capogrossi M. C., Meola G., Martelli F., Deregulated microRNAs in myotonic dystrophy type 2. PloS ONE 2012 7 6 e39732
42. Dmitriev P., Stankevicins L., Ansseau E., Petrov A., Barat A., Dessen P., Robert T., Turki A., Lazar V., Labourier E., Belayew A., Carnac G., Laoudj-Chenivesse D., Lipinski M., Vassetzky Y. S., Defective regulation of microRNA target genes in myoblasts from facioscapulohumeral dystrophy patients. Journal of Biological Chemistry 2013 288 49 10.1074/jbc.M113.504522
43. Mizuno H., Nakamura A., Aoki Y., Ito N., Kishi S., Yamamoto K., Sekiguchi M., Takeda S., Hashido K., Identification of muscle-specific microRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophy. PLoS ONE 2011 6 3 2-s2.0-79953319448 10.1371/journal.pone. 0018388 e18388
44. Vignier N., Amor F., Fogel P., Duvallet A., Poupiot J., Charrier S., Arock M., Montus M., Nelson I., Richard I., Carrier L., Servais L., Voit T., Bonne G., Israeli D., Distinctive serum miRNA profile in mouse models of striated muscular pathologies. PloS ONE 2013 8 2 e55281
45. Buckingham M., Vincent S. D., Distinct and dynamic myogenic populations in the vertebrate embryo. Current Opinion in Genetics and Development 2009 19 5 444 453 2-s2.0-71849109430 10.1016/j.gde.2009.08.001
46. Carvajal J. J., Rigby P. W. J., Regulation of gene expression in vertebrate skeletal muscle. Experimental Cell Research 2010 316 18 3014 3018 2-s2.0-77957674446 10.1016/j.yexcr.2010.07.005
47. O'Rourke J. R., Georges S. A., Seay H. R., Tapscott S. J., McManus M. T., Goldhamer D. J., Swanson M. S., Harfe B. D., Essential role for Dicer during skeletal muscle development. Developmental Biology 2007 311 2 359 368 2-s2.0-35748958766 10.1016/j.ydbio.2007.08.032 (Pubitemid 350046531)
48. Lagos-Quintana M., Rauhut R., Yalcin A., Meyer J., Lendeckel W., Tuschl T., Identification of tissue-specific microRNAs from mouse. Current Biology 2002 12 9 735 739 2-s2.0-0037197803 10.1016/S0960-9822(02)00809-6 (Pubitemid 34455427)
49. Zhao Y., Samal E., Srivastava D., Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 2005 436 7048 214 220 2-s2.0-22444437609 10.1038/nature03817 (Pubitemid 41021266)
50. Sokol N. S., Ambros V., Mesodermally expressed Drosophila microRNA-1 is regulated by Twist and is required in muscles during larval growth. Genes and Development 2005 19 19 2343 2354 2-s2.0-25844460031 10.1101/gad.1356105 (Pubitemid 41396911)
51. Simon D. J., Madison J. M., Conery A. L., Thompson-Peer K. L., Soskis M., Ruvkun G. B., Kaplan J. M., Kim J. K., The microRNA miR-1 regulates a MEF-2-dependent retrograde signal at neuromuscular junctions. Cell 2008 133 5 903 915 2-s2.0-43949104827 10.1016/j.cell.2008.04.035 (Pubitemid 351707687)
52. Anderson C., Catoe H., Werner R., MIR-206 regulates connexin43 expression during skeletal muscle development. Nucleic Acids Research 2006 34 20 5863 5871 2-s2.0-33845677227 10.1093/nar/gkl743 (Pubitemid 44941165)
53. Chen J.-F., Mandel E. M., Thomson J. M., Wu Q., Callis T. E., Hammond S. M., Conlon F. L., Wang D.-Z., The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nature Genetics 2006 38 2 228 233 2-s2.0-31744432337 10.1038/ng1725 (Pubitemid 43177239)
54. Hak K. K., Yong S. L., Sivaprasad U., Malhotra A., Dutta A., Muscle-specific microRNA miR-206 promotes muscle differentiation. Journal of Cell Biology 2006 174 5 677 687 2-s2.0-33748102321 10.1083/jcb.200603008 (Pubitemid 44306724)
55. Rosenberg M. I., Georges S. A., Asawachaicharn A., Analau E., Tapscott S. J., MyoD inhibits Fstl1 and Utrn expression by inducing transcription of miR-206. Journal of Cell Biology 2006 175 1 77 85 2-s2.0-33749557894 10.1083/jcb.200603039 (Pubitemid 44537200)
56. Wienholds E., Kloosterman W. P., Miska E., Alvarez-Saavedra E., Berezikov E., de Bruijn E., Horvitz H. R., Kauppinen S., Plasterk R. H. A., MicroRNA expression in zebrafish embryonic development. Mechanisms of Development 2005 122 S149 S150
57. Sweetman D., Rathjen T., Jefferson M., Wheeler G., Smith T. G., Wheeler G. N., Münsterberg A., Dalmay T., Erratum: FGF-4 signaling is involved in mir-206 expression in developing somites of chicken embryos (Developmental Dynamics 235 (2185-2191)). Developmental Dynamics 2006 235 10 2905 2-s2.0-33749242999 10.1002/dvdy.20937 (Pubitemid 44484524)
58. Rao P. K., Kumar R. M., Farkhondeh M., Baskerville S., Lodish H. F., Myogenic factors that regulate expression of muscle-specific microRNAs. Proceedings of the National Academy of Sciences of the United States of America 2006 103 23 8721 8726 2-s2.0-33745032991 10.1073/pnas.0602831103 (Pubitemid 43878086)
59. Sweetman D., Goljanek K., Rathjen T., Oustanina S., Braun T., Dalmay T., Münsterberg A., Specific requirements of MRFs for the expression of muscle specific microRNAs, miR-1, miR-206 and miR-133. Developmental Biology 2008 321 2 491 499 2-s2.0-51449101459 10.1016/j.ydbio.2008.06.019
60. Alteri A., De Vito F., Messina G., Pompili M., Calconi A., Visca P., Mottolese M., Presutti C., Grossi M., Cyclin D1 is a major target of miR-206 in cell differentiation and transformation. Cell Cycle 2013 12 24
61. Hirai H., Verma M., Watanabe S., Tastad C., Asakura Y., Asakura A., MyoD regulates apoptosis of myoblasts through microRNA-mediated down-regulation of Pax3. Journal of Cell Biology 2010 191 2 347 365 2-s2.0-77958469790 10.1083/jcb.201006025
62. Chen J.-F., Tao Y., Li J., Deng Z., Yan Z., Xiao X., Wang D.-Z., microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7. Journal of Cell Biology 2010 190 5 867 879 2-s2.0-77956370863 10.1083/jcb.200911036
63. Dey B. K., Gagan J., Dutta A., miR-206 and -486 induce myoblast differentiation by downregulating Pax7 (Molecular and Cellular Biology (2010) 31, 1, (203-214)). Molecular and Cellular Biology 2011 31 6 1329 2-s2.0-79952261849 10.1128/MCB.05013-11
64. Elia L., Contu R., Quintavalle M., Varrone F., Chimenti C., Russo M. A., Cimino V., De Marinis L., Frustaci A., Catalucci D., Condorelli G., Reciprocal regulation of microrna-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions. Circulation 2009 120 23 2377 2385 2-s2.0-73449086958 10.1161/CIRCULATIONAHA.109.879429
65. van Rooij E., Quiat D., Johnson B. A., Sutherland L. B., Qi X., Richardson J. A., Kelm R. J. Jr., Olson E. N., A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Developmental Cell 2009 17 5 662 673 2-s2.0-71549165765 10.1016/j.devcel.2009.10.013
66. Crist C. G., Montarras D., Pallafacchina G., Rocancourt D., Cumano A., Conway S. J., Buckinghama M., Muscle stem cell behavior is modified by microRNA-27 regulation of Pax3 expression. Proceedings of the National Academy of Sciences of the United States of America 2009 106 32 13383 13387 2-s2.0-69449099803 10.1073/pnas.0900210106
67. Dey B. K., Gagan J., Yan Z., Dutta A., miR-26a is required for skeletal muscle differentiation and regeneration in mice. Genes & Development 2012 26 19 2180 2191
68. Sun F., Wang J., Pan Q., Yu Y., Zhang Y., Wan Y., Wang J., Li X., Hong A., Characterization of function and regulation of miR-24-1 and miR-31. Biochemical and Biophysical Research Communications 2009 380 3 660 665 2-s2.0-60549103514 10.1016/j.bbrc.2009.01.161
69. Winbanks C. E., Wang B., Beyer C., Koh P., White L., Kantharidis P., Gregorevic P., TGF- β regulates miR-206 and miR-29 to control myogenic differentiation through regulation of HDAC4. Journal of Biological Chemistry 2011 286 16 13805 13814 2-s2.0-79954623314 10.1074/jbc.M110.192625
70. Cardinalli B., Castellani L., Fasanaro P., Basso A., Alemà S., Martelli F., Falcone G., Microrna-221 and microRNA-222 modulate differentiation and maturation of skeletal muscle cells. PLoS ONE 2009 4 10 2-s2.0-70449558856 10.1371/journal.pone.0007607 e7607
71. Ge Y., Sun Y., Chen J., IGF-II is regulated by microRNA-125b in skeletal myogenesis. Journal of Cell Biology 2011 192 1 69 81 2-s2.0-78651301788 10.1083/jcb.201007165
72. Naguibneva I., Ameyar-Zazoua M., Polesskaya A., Ait-Si-Ali S., Groisman R., Souidi M., Cuvellier S., Harel-Bellan A., The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation. Nature Cell Biology 2006 8 3 278 284 2-s2.0-33644779735 10.1038/ncb1373 (Pubitemid 43336070)
73. Gagan J., Dey B. K., Layer R., Yan Z., Dutta A., MicroRNA-378 targets the myogenic repressor MyoR during myoblast differentiation. Journal of Biological Chemistry 2011 286 22 19431 19438 2-s2.0-79957626588 10.1074/jbc.M111.219006
74. Juan A. H., Kumar R. M., Marx J. G., Young R. A., Sartorelli V., Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells. Molecular Cell 2009 36 1 61 74 2-s2.0-70349764482 10.1016/j.molcel.2009.08.008
75. Liu J., Luo X.-J., Xiong A.-W., Zhang Z.-D., Yue S., Zhu M.-S., Cheng S. Y., MicroRNA-214 promotes myogenic differentiation by facilitating exit from mitosis via down-regulation of proto-oncogene N-ras. Journal of Biological Chemistry 2010 285 34 26599 26607 2-s2.0-77956201393 10.1074/jbc.M110.115824
76. Wei W., He H. B., Zhang W. Y., Zhang H. X., Bai J. B., Liu H. Z., Cao J. H., Chang K. C., Li X. Y., Zhao S. H., miR-29 targets Akt3 to reduce proliferation and facilitate differentiation of myoblasts in skeletal muscle development. Cell Death & Disease 2013 4
77. Emery A. E. H., Muscular dystrophy into the new millennium. Neuromuscular Disorders 2002 12 4 343 349 2-s2.0-0036227796 10.1016/S0960-8966(01)00303-0 (Pubitemid 34327208)
78. Monaco A. P., Neve R. L., Colletti-Feener C., Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature 1986 323 6089 646 650 2-s2.0-0022496289 (Pubitemid 16008561)
79. Burghes A. H. M., Logan C., Hu X., Belfall B., Worton R. G., Ray P. N., A cDNA clone from the Duchenne/Becker muscular dystrophy gene. Nature 1987 328 6129 434 437 2-s2.0-0023274891 (Pubitemid 17097776)
80. Hoffman E. P., Brown R. H. Jr., Kunkel L. M., Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987 51 6 919 928 2-s2.0-0023614188
81. Koening M., Hoffman E. P., Bertelson C. J., Monaco A. P., Feener C., Kunkel L. M., Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 1987 50 3 509 517 2-s2.0-0023614271 (Pubitemid 18098338)
82. Hoffman E. P., Fischbeck K. H., Brown R. H., Johnson M., Medori R., Loike J. D., Harris J. B., Waterston R., Brooke M., Specht L., Kupsky W., Chamberlain J., Caskey C. T., Shapiro F., Kunkel L. M., Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. The New England Journal of Medicine 1988 318 21 1363 1368 2-s2.0-0023906647
83. Koening M., Beggs A. H., Moyer M., Scherpf S., Heindrich K., Bettecken T., Meng G., Muller C. R., Lindlof M., Kaariainen H., De la Chapelle A., Kiuru A., Savontaus M.-L., Gilgenkrantz H., Recan D., Chelly J., Kaplan J.-C., Covone A. E., Archidiacono N., The molecular basis for Duchenne versus becker muscular dystrophy: correlation of severity with type of deletion. The American Journal of Human Genetics 1989 45 4 498 506 2-s2.0-0024466501 (Pubitemid 19261437)
84. Twayana S., Legnini I., Cesana M., Cacchiarelli D., Morlando M., Bozzoni I., Biogenesis and function of non-coding RNAs in muscle differentiation and in Duchenne muscular dystrophy. Biochemical Society Transactions 2013 41 844 849 10.1042/BST20120353
85. Udd B., Krahe R., The myotonic dystrophies: molecular, clinical, and therapeutic challenges. The Lancet Neurology 2012 11 10 891 905 10.1016/S1474-4422(12)70204-1
86. Mankodi A., Logigian E., Callahan L., McClain C., White R., Henderson D., Krym M., Thornton C. A., Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 2000 289 5485 1769 1772 2-s2.0-0034622926 10.1126/science.289.5485.1769
87. Garcia-Lopez A., Monferrer L., Garcia-Alcover I., Vicente-Crespo M., Alvarez-Abril M. C., Artero R. D., Genetic and chemical modifiers of a CUG toxicity model in Drosophila. PLoS ONE 2008 3 2 2-s2.0-45749099371 10.1371/journal.pone.0001595 e1595 (Pubitemid 351864729)
88. Chen K.-Y., Pan H., Lin M.-J., Li Y.-Y., Wang L.-C., Wu Y.-C., Hsiao K.-M., Length-dependent toxicity of untranslated CUG repeats on Caenorhabditis elegans. Biochemical and Biophysical Research Communications 2007 352 3 774 779 2-s2.0-33845327154 10.1016/j.bbrc.2006.11.102 (Pubitemid 44880322)
89. Du H., Cline M. S., Osborne R. J., Tuttle D. L., Clark T. A., Donohue J. P., Hall M. P., Shiue L., Swanson M. S., Thornton C. A., Ares M. Jr., Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy. Nature Structural and Molecular Biology 2010 17 2 187 193 2-s2.0-76249102027 10.1038/nsmb.1720
90. Jiang H., Mankodi A., Swanson M. S., Moxley R. T., Thornton C. A., Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Human Molecular Genetics 2004 13 24 3079 3088 2-s2.0-11044233708 10.1093/hmg/ddh327 (Pubitemid 40045262)
91. Kanadia R. N., Johnstone K. A., Mankodi A., Lungu C., Thornton C. A., Esson D., Timmers A. M., Hauswirth W. W., Swanson M. S., A muscleblind knockout model for myotonic dystrophy. Science 2003 302 5652 1978 1980 2-s2.0-0346243804 10.1126/science.1088583 (Pubitemid 37523508)
92. Krol J., Fiszer A., Mykowska A., Sobczak K., de Mezer M., Krzyzosiak W. J., Ribonuclease dicer cleaves triplet repeat hairpins into shorter repeats that silence specific targets. Molecular Cell 2007 25 4 575 586 2-s2.0-33847077134 10.1016/j.molcel.2007.01.031 (Pubitemid 46274449)
93. Bañez-Coronel M., Porta S., Kagerbauer B., Mateu-Huertas E., Pantano L., Ferrer I., Guzmán M., Estivill X., Martí E., A pathogenic mechanism in huntington's disease involves small CAG-repeated RNAs with neurotoxic activity. PLoS Genetics 2012 8 2 2-s2.0-84859179041 10.1371/journal.pgen.1002481 e1002481
94. Snider L., Asawachaicharn A., Tyler A. E., Geng L. N., Petek L. M., Maves L., Miller D. G., Lemmers R. J. L. F., Winokur S. T., Tawil R., van der Maarel S. M., Filippova G. N., Tapscott S. J., RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: New candidates for the pathophysiology of facioscapulohumeral dystrophy. Human Molecular Genetics 2009 18 13 2414 2430 2-s2.0-67249104052 10.1093/hmg/ddp180
95. Cabianca D., Casa V., Bodega B., Xynos A., Ginelli E., Tanaka Y., Gabellini D., A long ncRNA links copy number variation to a polycomb/trithorax epigenetic switch in FSHD muscular dystrophy. Cell 2012 149 4 2-s2.0-84860159993 10.1016/j.cell.2012.03.035
96. Kowaljow V., Marcowycz A., Ansseau E., Conde C. B., Sauvage S., Mattéotti C., Arias C., Corona E. D., Nuñez N. G., Leo O., Wattiez R., Figlewicz D., Laoudj-Chenivesse D., Belayew A., Coppée F., Rosa A. L., The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. Neuromuscular Disorders 2007 17 8 611 623 2-s2.0-34447104322 10.1016/j.nmd.2007.04.002 (Pubitemid 47030917)
97. Bosnakovski D., Lamb S., Simsek T., Xu Z., Belayew A., Perlingeiro R., Kyba M., DUX4c, an FSHD candidate gene, interferes with myogenic regulators and abolishes myoblast differentiation. Experimental Neurology 2008 214 1 87 96 2-s2.0-53949112045 10.1016/j.expneurol.2008.07.022
98. Mendell J. R., Moxley R. T., Griggs R. C., Brooke M. H., Fenichel G. M., Miller J. P., King W., Signore L., Pandya S., Florence J., Schierbecker J., Robison J., Kaiser K., Mandel S., Arfken C., Gilder B., Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy. The New England Journal of Medicine 1989 320 24 1592 1597 2-s2.0-0024332294 (Pubitemid 19154573)
99. Griggs R. C., Moxley R. T. III, Mendell J. R., Fenichel G. M., Brooke M. H., Pestronk A., Miller J. P., Prednisone in Duchenne dystrophy: a randomized, controlled trial defining the time course and dose response. Archives of Neurology 1991 48 4 383 388 2-s2.0-0025869545
100. Biggar W. D., Harris V. A., Eliasoph L., Alman B., Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade. Neuromuscular Disorders 2006 16 4 249 255 2-s2.0-33646478253 10.1016/j.nmd.2006.01.010
101. Ruegg U. T., Pharmacological prospects in the treatment of Duchenne muscular dystrophy. Current Opinion in Neurology 2013 26 5 577 584 10.1097/WCO.0b013e328364fbaf
102. Leung D. G., Wagner K. R., Therapeutic advances in muscular dystrophy. Annals of Neurology 2013 74 3 404 411
103. Logigian E. L., Martens W. B., Moxley R. T., McDermott M. P., Dilek N., Wiegner A. W., Pearson A. T., Barbieri C. A., Annis C. L., Thornton C. A., Moxley R. T., Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1. Neurology 2010 74 18 1441 1448 2-s2.0-77951848201 10.1212/WNL.0b013e3181dc1a3a
104. Abdel-Hamid H., Clemens P. R., Pharmacological therapies for muscular dystrophies. Current Opinion in Neurology 2012 25 5 604 608 10.1097/WCO. 0b013e328357f44c
105. Groh W. J., Groh M. R., Saha C., Kincaid J. C., Simmons Z., Ciafaloni E., Pourmand R., Otten R. F., Bhakta D., Nair G. V., Marashdeh M. M., Zipes D. P., Pascuzzi R. M., Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. The New England Journal of Medicine 2008 358 25 2688 2697 2-s2.0-45549084293 10.1056/NEJMoa062800 (Pubitemid 351860861)
106. Tawil R., Facioscapulohumeral muscular dystrophy. Neurotherapeutics 2008 5 4 601 606 2-s2.0-53049110907 10.1016/j.nurt.2008.07.005
107. Chen S.-Y., Wang Y., Telen M. J., Chi J.-T., The genomic analysis of erythrocyte microRNA expression in sickle cell diseases. PLoS ONE 2008 3 6 2-s2.0-48649100900 10.1371/journal.pone.0002360 e2360
108. Mitchell P. S., Parkin R. K., Kroh E. M., Fritz B. R., Wyman S. K., Pogosova-Agadjanyan E. L., Peterson A., Noteboom J., O'Briant K. C., Allen A., Lin D. W., Urban N., Drescher C. W., Knudsen B. S., Stirewalt D. L., Gentleman R., Vessella R. L., Nelson P. S., Martin D. B., Tewari M., Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences of the United States of America 2008 105 30 10513 10518 2-s2.0-48749122914 10.1073/pnas.0804549105
109. Goljanek-Whysall K., Sweetman D., Munsterberg A. E., MicroRNAs in skeletal muscle differentiation and disease. Clinical Science 2012 123 11-12 611 625 10.1042/CS20110634
110. Janssen H. L. A., Reesink H. W., Lawitz E. J., Zeuzem S., Rodriguez-Torres M., Patel K., van der Meer A. J., Patick A. K., Chen A., Zhou Y., Persson R., King B. D., Kauppinen S., Levin A. A., Hodges M. R., Treatment of HCV infection by targeting microRNA. The New England Journal of Medicine 2013 368 18 1685 1694 10.1056/NEJMoa1209026
111. Davidson B. L., McCray P. B., Current prospects for RNA interference-based therapies. Nature Reviews Genetics 2011 12 5 329 340 2-s2.0-79954580272 10.1038/nrg2968
112. Wang V., Wu W., MicroRNA-based therapeutics for cancer. BioDrugs 2009 23 1 15 23 2-s2.0-64149121172 10.2165/00063030-200923010-00002
113. Ebert M. S., Sharp P. A., Emerging roles for natural microRNA sponges. Current Biology 2010 20 19 R858 R861 2-s2.0-77957850291 10.1016/j.cub.2010.08. 052
114. Liu Y. P., Berkhout B., MiRNA cassettes in viral vectors: problems and solutions. Biochimica et Biophysica Acta 2011 1809 11-12 732 745 2-s2.0-80655124686 10.1016/j.bbagrm.2011.05.014
115. Gutschner T., Hammerle M., Eissmann M., Hsu J., Kim Y., Hung G., Revenko A., Arun G., Stentrup M., Gross M., Zornig M., MacLeod A. R., Spector D. L., Diederichs S., The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Research 2013 73 3 1180 1189 10.1158/0008-5472.CAN-12-2850
116. Poller W., Tank J., Skurk C., Gast M., Cardiovascular RNA interference therapy: the broadening tool and target spectrum. Circulation Research 2013 113 5 588 602 10.1161/CIRCRESAHA.113.301056
117. Hauptman N., Glavac D., MicroRNAs and long non-coding RNAs: prospects in diagnostics and therapy of cancer. Radiology and Oncology 2013 47 4 311 318
118. Li C. H., Chen Y. C., Targeting long non-coding RNAs in cancers: progress and prospects. International Journal of Biochemistry & Cell Biology 2013 45 8 1895 1910
119. Weinberg M. S., Morris K. V., Long non-coding RNA targeting and transcriptional de-repression. Nucleic Acid Therapeutics 2013 23 1 9 14
120. Ip J. Y., Nakagawa S., Long non-coding RNAs in nuclear bodies. Development Growth and Differentiation 2012 54 1 44 54 2-s2.0-84855956560 10.1111/j.1440-169X.2011.01303.x
121. Mulders S. A. M., van den Broek W. J. A. A., Wheeler T. M., Croes H. J. E., Van Kuik-Romeijn P., De Kimpe S. J., Furling D., Platenburg G. J., Gourdon G., Thornton C. A., Wieringa B., Wansink D. G., Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy. Proceedings of the National Academy of Sciences of the United States of America 2009 106 33 13915 13920 2-s2.0-69549126597 10.1073/pnas.0905780106
122. Sobczak K., Wheeler T. M., Wang W. L., Thornton C. A., RNA interference targeting CUG repeats in a mouse model of myotonic dystrophy. Molecular Therapy 2013 21 2 380 387
123. Wheeler T. M., Leger A. J., Pandey S. K., MacLeod A. R., Nakamori M., Cheng S. H., Wentworth B. M., Bennett C. F., Thornton C. A., Targeting nuclear RNA for in vivo correction of myotonic dystrophy. Nature 2012 488 7409 111 115 10.1038/nature11362